JMIR Publications

ABSTRACT

Background:

The Clinical Data Interchange Standards Consortium (CDISC) has become the cornerstone of regulatory data submission frameworks for pharmaceutical and biotechnology organizations worldwide. Despite mandatory compliance requirements from the U.S. Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), clinical data teams continue to face persistent operational barriers, including controlled terminology misuse, non-standard domain mapping ambiguity, insufficient validation automation, and submission deficiencies that precipitate costly review cycles. This article addresses the following research question: what implementation strategies most effectively reduce submission deficiency rates and cycle times across multi-program pharmaceutical development organizations? To answer this, the article presents actionable technical guidance for clinical data managers, biostatisticians, and statistical programmers engaged in CDISC compliance workflows. Beyond synthesizing existing guidance, this work introduces the CDISC Implementation Maturity Model (CIMM), a five-level framework enabling organizations to assess their current implementation capability and identify targeted improvements. Strategies examined include domain selection and controlled terminology governance, template-based and metadata-driven automation architectures, multi-layered validation frameworks, and approaches for handling non-standard assessments and complex efficacy endpoints. A formal limitations section and directions for future empirical research are also provided. The practical frameworks presented are intended to reduce submission cycle times, improve first-cycle regulatory acceptance rates, and build durable institutional capability in clinical data standards.

Objective:

This review addresses the following research question: which implementation strategies most effectively reduce submission deficiency rates and cycle times across multi-program pharmaceutical development organizations, and how can organizations systematically assess their implementation maturity?

Methods:

The review synthesizes published implementation literature, regulatory and standards-body guidance, and documented practitioner experience into integrated technical guidance for clinical data managers, biostatisticians, and statistical programmers engaged in CDISC compliance workflows. Drawing on the conceptual principles of staged capability maturity modeling, it derives a structured framework for characterizing organizational CDISC implementation capability.

Results:

Strategies examined include domain selection and controlled terminology governance, template-based and metadata-driven automation architectures, multi-layered validation frameworks, and approaches for handling non-standard assessments and complex efficacy endpoints. Beyond synthesizing existing guidance, this work introduces the CDISC Implementation Maturity Model (CIMM), a five-level framework enabling organizations to assess their current implementation capability across five operational dimensions—process standardization, automation coverage, terminology governance, validation integration, and institutional knowledge distribution—and to identify targeted improvements.

Conclusions:

The practical frameworks presented are intended to reduce submission cycle times, improve first-cycle regulatory acceptance rates, and build durable institutional capability in clinical data standards. A formal limitations section and directions for future empirical research, including validation of the CIMM against observed submission outcomes, are also provided.